Top

Published in:

01-08-2002 | Original Article

High Survivin Expression is Associated with Reduced Apoptosis in Rectal Cancer and May Predict Disease-Free Survival after Preoperative Radiochemotherapy and Surgical Resection

Authors: Franz Rödel, Jörg Hoffmann, Gerhard G. Grabenbauer, Thomas Papadopoulos, Christian Weiß, Klaus Günther, Christoph Schick, Rolf Sauer, Claus Rödel

Published in: Strahlentherapie und Onkologie | Issue 8/2002

Title: High Survivin Expression is Associated with Reduced Apoptosis in Rectal Cancer and May Predict Disease-Free Survival after Preoperative Radiochemotherapy and Surgical Resection
Authors: Franz Rödel
Jörg Hoffmann
Gerhard G. Grabenbauer
Thomas Papadopoulos
Christian Weiß
Klaus Günther
Christoph Schick
Rolf Sauer
Claus Rödel
Publication date: 01-08-2002
Publisher: Urban & Vogel
Published in: Strahlentherapie und Onkologie / Issue 8/2002
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-002-1003-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

High Survivin Expression is Associated with Reduced Apoptosis in Rectal Cancer and May Predict Disease-Free Survival after Preoperative Radiochemotherapy and Surgical Resection

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 8/2002

The Value of PSA Measurements at 30 Gy, 50 Gy and 60 Gy for Dose Limitation in Patients with Radiotherapy for PSA Increase after Radical Prostatectomy

Anemia and Elevated Systemic Levels of Vascular Endothelial Growth Factor (VEGF)

Immunohistochemically Detected p53 Mutations in Epithelial Tumors and Results of Treatment with Chemotherapy and Radiotherapy A Treatment-Specific Overview of the Clinical Data

Re-Irradiation of the Human Spinal Cord

Ovarielle Suppression in der adjuvanten Therapie des Mammakarzinoms: GnRH-Analoga, Ovarektomie oder Radiomenolyse –“Stein der Weisen” statt “Kammer des Schreckens”?

Fractionated Intraluminal HDR 192Ir Brachytherapy as Palliative Treatment in Patients with Endobronchial Metastases from Non-Bronchogenic Primaries